Gyre Therapeutics Appoints Three New Directors
Gyre Therapeutics announced the appointment of CEO Yue Xiong and veterans Maxwell Kirkby and Claire Weston to its board, effective August 1, 2026. This expansion of scientific and governance expertise is intended to bolster Gyre's cross-border drug development efforts and strengthen its clinical pipeline management.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day